Optimizing clinical management of neonatal hypoglycemia – a quality improvement project

• Conditions: P70; Transitory disorders of carbohydrate metabolism specific to fetus and newborn

• Registration Number: DRKS00028165
• Lead Sponsor: niversitätsmedizin Göttingen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

children of diabetic mothers (gestational diabetes or pre-existing diabetes)
- hypothrophic (< 10. percentile) and hypertrophic (> 90. percentile) neonates
- premature babies (36 - 36;6 weeks of pregnancy, excluding those, who were hospitalized anyway)
- extended pregnancy (= 42+0 weeks of pregnancy)
- maternal medication with beta blockers
- perinatal acidosis (pH < 7,1)
- maternal eclampsia or arterial hypertension (RR > 140 / 90 mmHg)

Exclusion Criteria

- premature babies (< 36 weeks of pregnancy)
- neonates who were hospitalized at the neonatal department for another reason

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Validation of the successful implementation of the AWMF-guideline and a resulting improvement of the hypoglycemia management.

Secondary Outcome Measures

Name	Time	Method
Effectiveness comparison of the different neonatal hypoglycemia treatment strategies at the three birth clinics named above.